HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build
HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions
| Active as of 2020-06-29 |
{
"resourceType" : "PlanDefinition",
"id" : "ColoRectal",
"meta" : {
"profile" : [
🔗 "http://hl7.org.nz/fhir/StructureDefinition/CcaPlanDefinition"
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Plan for ColoRectal cancer. There is a single cycle with 2 drug administrations</div>"
},
"contained" : [
{
"resourceType" : "ActivityDefinition",
"id" : "ActTragacanth",
"meta" : {
"profile" : [
🔗 "http://hl7.org.nz/fhir/StructureDefinition/CcaActivityDefinition"
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Tragacanth administration, 3mg over 3 hours by continuous IV infusion</div>"
},
"status" : "draft",
"productCodeableConcept" : {
"coding" : [
{
"system" : "https://nzulm.org.nz/nzmt",
"code" : "10711851000116105",
"display" : "Tragacanth"
}
]
},
"dosage" : [
{
"text" : "3 mg over 3 hours by IV infusion",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "180177004",
"display" : "continuous intravenous infusion"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 3,
"system" : "http://unitsofmeasure.org",
"code" : "mg"
},
"rateQuantity" : {
"value" : 3,
"system" : "http://unitsofmeasure.org",
"code" : "h"
}
}
]
}
]
}
],
"extension" : [
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions",
"valueMarkdown" : "Only for women"
},
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-disclaimer",
"valueMarkdown" : "Developed with the best of intentions."
},
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-regimen-type",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "dummy"
}
],
"text" : "Folfox"
}
},
{
"extension" : [
{
"url" : "factor",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "TOUPDATE-SUPPORT4",
"display" : "Diarrhoea risk"
}
]
}
},
{
"url" : "value",
"valueCodeableConcept" : {
"text" : "low"
}
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor"
},
{
"extension" : [
{
"url" : "factor",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "TOUPDATE-SUPPORT8",
"display" : "AntiFungal Prophylaxis"
}
]
}
},
{
"url" : "value",
"valueCodeableConcept" : {
"text" : "low"
}
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor"
},
{
"extension" : [
{
"url" : "factor",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "TOUPDATE-SUPPORT2",
"display" : "Hypersensitivity / Infusion related reaction ris"
}
]
}
},
{
"url" : "value",
"valueCodeableConcept" : {
"text" : "low"
}
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-support-factor"
}
],
"url" : "http://hl7.org.nz/fhir/ig/cca/PlanDefinition/ColoRectal",
"version" : "0.1.0",
"title" : "Colorectal Adjuvant FOLFOX (a7)",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "clinical-protocol"
}
]
},
"status" : "active",
"_status" : {
"extension" : [
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-additional-plan-status",
"valueCode" : "review"
}
]
},
"experimental" : false,
"date" : "2020-06-29T20:14:18.417+12:00",
"publisher" : "Te Aho o Te Kahu, Cancer Control Agency",
"description" : "A drug treatment regimen for Colorectal cancer. Plan is still under review.",
"useContext" : [
{
"code" : {
"system" : "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code" : "focus"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "781382000",
"display" : "Colorectal cancer"
}
]
}
}
],
"relatedArtifact" : [
{
"type" : "citation",
"display" : "test",
"url" : "http://www.ncbi.nlm.nih.gov/pubmed/23434",
"document" : {
"url" : "http://www.ncbi.nlm.nih.gov/pubmed/23434"
}
},
{
"type" : "citation",
"display" : "test2",
"url" : "http://www.ncbi.nlm.nih.gov/pubmed/34324",
"document" : {
"url" : "http://www.ncbi.nlm.nih.gov/pubmed/34324"
}
}
],
"action" : [
{
"extension" : [
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions",
"valueMarkdown" : "Ensure not pregnant before starting"
}
],
"title" : "This is the only cycle in the regimen.",
"description" : "Administration of Cabergoline and Tragacanth. Cycle length 14 days",
"timingTiming" : {
"repeat" : {
"count" : 1,
"duration" : 14,
"durationUnit" : "d"
}
},
"selectionBehavior" : "all",
"action" : [
{
"extension" : [
{
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-plan-instructions",
"valueMarkdown" : "Keep a close eye for side effects"
},
{
"extension" : [
{
"url" : "day",
"valueInteger" : 1
},
{
"url" : "instructions",
"valueString" : "Specific instructions for the day 1 administration"
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days"
},
{
"extension" : [
{
"url" : "day",
"valueInteger" : 4
},
{
"url" : "instructions",
"valueString" : "Specific instructions for the day 4 administration"
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days"
}
],
"description" : "2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes",
"definitionCanonical" : "#act-cabergoline"
},
{
"extension" : [
{
"extension" : [
{
"url" : "day",
"valueInteger" : 2
},
{
"url" : "instructions",
"valueString" : "Specific instructions for the day 2 administration"
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days"
},
{
"extension" : [
{
"url" : "day",
"valueInteger" : 3
},
{
"url" : "instructions",
"valueString" : "Specific instructions for the day 3 administration"
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days"
},
{
"extension" : [
{
"url" : "day",
"valueInteger" : 4
},
{
"url" : "instructions",
"valueString" : "Specific instructions for the day 4 administration"
}
],
"url" : "http://hl7.org.nz/fhir/StructureDefinition/sact-timing-of-days"
}
],
"description" : "3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours",
"definitionCanonical" : "#act-tragacanth"
}
]
}
]
}